Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07448376) titled 'EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases' on Feb. 25.

Study Type: Observational [Patient Registry]

Primary Sponsor: Huazhong University of Science and Technology

Condition: CTCs Pancreatic Cancer Liver Metastases Relapse Borderline Resectable Pancreatic Cancer Resectable Pancreatic Cancers EUS

Intervention: Diagnostic Test: CTC

Recruitment Status: Not recruiting

Date of First Enrollment: March 1, 2026

Target Sample Size: 20

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07448376

Published by HT Digital Content Services...